Hospital M. Scarlato, Operative Unit of Anesthesia and Intensive Care, ASL Salerno, Italy.
Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):205-10.
The analgesic efficacy of two fixed combinations of tramadol/paracetamol (TP 37.5/325 mg) and codeine/paracetamol (CP 30/500 mg) was compared in 122 patients undergoing one-day surgical procedures (hallux valgus, haemorrhoidectomy, varicectomy and inguinal hernia repair), randomly treated with TP 37.5/325 mg or CP 30/500 mg one tablet after surgery ended, followed by one tablet four times daily for 48 hours.
Pain was assessed by a Verbal Rating Scale (VRS). Whenever the VRS score was > or = 3, the patient was given a "rescue medication" (tramadol 50 mg s.c.). The quality of life (time to return to normal daily activities, nightly rest, appetite, mood, deambulation, and self-care) was assessed in the postoperative period. Patients were asked to give their judgment on the surgical procedure and postoperative outcome.
The results indicate that TP 37.5/325 mg was superior to CP 30/500 mg in terms of higher analgesic efficacy (VSR at 24 hours: CP 30/500, 2.52 +/- 0.86 vs. TP 37.5/325, 1.40 +/- 0.76; p < 0.001), less patients reporting adverse events (CP 30/500: 62% vs. TP 37.5/325: 36%; p < 0.01), less patients requiring rescue medications (CP 30/500: 18.2% vs. TP 37.5/325: 5.5%; p < 0.01), and more favorable judgment (scored "excellent" by 16% and 54.5% of CP 30/500 or TP 37.5/325-treated patients, respectively; p < 0.001).
We conclude that a fixed association of tramadol/paracetamol is a valuable and safe tool for pain management in day hospital surgery, especially whenever any effort is done to reduce the time for hospitalization.
比较曲马多/对乙酰氨基酚(TP 37.5/325 mg)和可待因/对乙酰氨基酚(CP 30/500 mg)两种固定组合在 122 例接受一日手术(拇囊炎、痔疮切除术、精索静脉曲张和腹股沟疝修补术)的患者中的镇痛效果,这些患者术后随机接受 TP 37.5/325 mg 或 CP 30/500 mg 一片,随后每 4 小时服用一片,共 48 小时。
采用语言评分量表(VRS)评估疼痛。只要 VRS 评分>或=3,患者即给予“解救药物”(曲马多 50 mg 皮下注射)。术后评估生活质量(恢复正常日常活动的时间、夜间休息、食欲、情绪、活动能力和自理能力)。患者被要求对手术过程和术后结果进行判断。
结果表明,TP 37.5/325 mg 在镇痛效果方面优于 CP 30/500 mg(24 小时 VRS:CP 30/500,2.52 +/- 0.86 vs. TP 37.5/325,1.40 +/- 0.76;p < 0.001),报告不良反应的患者更少(CP 30/500:62% vs. TP 37.5/325:36%;p < 0.01),需要解救药物的患者更少(CP 30/500:18.2% vs. TP 37.5/325:5.5%;p < 0.01),且判断更有利(CP 30/500 或 TP 37.5/325 治疗的患者中分别有 16%和 54.5%评为“优秀”;p < 0.001)。
我们认为,曲马多/对乙酰氨基酚固定组合是日间手术中一种有价值且安全的镇痛工具,特别是在努力缩短住院时间的情况下。